Oppenheimer & Co. Inc. Sells 90,494 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Oppenheimer & Co. Inc. cut its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 44.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 113,860 shares of the company’s stock after selling 90,494 shares during the period. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $1,640,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Brown Brothers Harriman & Co. bought a new position in BlackRock Health Sciences Term Trust in the third quarter worth approximately $32,000. K2 Principal Fund L.P. purchased a new stake in shares of BlackRock Health Sciences Term Trust in the third quarter worth $158,000. Jane Street Group LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust in the third quarter worth $357,000. Kingswood Wealth Advisors LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth $420,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth $471,000.

BlackRock Health Sciences Term Trust Price Performance

Shares of NYSE BMEZ opened at $15.53 on Tuesday. The firm has a fifty day moving average price of $15.68 and a 200-day moving average price of $15.67. BlackRock Health Sciences Term Trust has a 1 year low of $14.27 and a 1 year high of $16.75.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were paid a $0.1773 dividend. The ex-dividend date was Friday, February 14th. This represents a $2.13 dividend on an annualized basis and a dividend yield of 13.70%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.